George Lasezkay | Chief Executive Officer |
Tom Ciulla | Chief Medical Officer, Chief Development Officer |
Charles Deignan | Chief Financial Officer |
Dr. Arshad Khanani | Managing Partner at Sierra Eye Associates, Clinical Associate Professor at the University of Nevada |
Jenny Kobin | Investor Relations |
Andreas Argyrides | Wedbush |
Annabel Samimy | Stifel |
John Wolleben | JMP Securities |
Yi Chen | H.C. Wainwright |
Serge Belanger | Needham & Company |
Mayank Mamtani | B. Riley |
Good morning, ladies and gentlemen, and welcome to the Clearside Biomedical Incorporated, Third Quarter 2022 Earnings Call. At this time all participants have been placed on a listen-only mode and the floor will be opened for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Jenny Kobin, with Investor Relations. Ma’am the floor is yours.
Good morning and thank you for joining us on the call this morning.